One of AIMS-2-TRIALS’ key goals is to build, develop and utilise a network for research scientists to reduce barriers to running clinical trials in autism. The Clinical Trials Network, which began as part of the EU-AIMS project, has expanded to 118 sites across 37 countries to create a unique European network of centers highly qualified in the diagnosis, treatment and support of autistic people and their families. Together with autism advocate organisations, partners from academia, healthcare and scientific associations, a collaborative project team has been established, to drive the development of on-going and future activities and projects.
AIMS-2-TRIALS consultation on data sharing
Autistic people may pay less attention to faces due to the way their brains process sensory information
Understanding autism: Linking genetics, brain structure and behaviour
Recognising faces: microstates
Measuring brain activity may help tailor support for autistic people